Environmental and health management of novel coronavirus disease (COVID-19) /
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | , , |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
London :
Academic Press,
2021.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Front Cover
- ENVIRONMENTAL AND HEALTH MANAGEMENT OF NOVELCORONA VIRUSDISEASE (COVID-19)
- ENVIRONMENTAL AND HEALTH MANAGEMENT OF NOVELCORONA VIRUSDISEASE (COVID-19)
- Copyright
- CONTENTS
- Contributors
- Foreword
- Preface
- Acknowledgments
- Introduction
- I
- Introduction, transmission routes and sampling technologies
- 1
- Updated insight into COVID-19 disease and health management to combat the pandemic
- 1.1 Introduction to SARS-CoV-2
- 1.2 Overview of SARS-CoV-2 virus
- 1.2.1 Genomic evolution of SARS-CoV-2
- 1.2.2 Transmission of coronaviruses
- 1.2.3 Clinical characteristics for COVID-19
- 1.2.4 Diagnostic detection of COVID-19
- 1.2.4.1 Preanalytical issues impacting the diagnosis
- 1.2.4.2 Primary diagnostic techniques for COVID-19 detection
- 1.2.4.2.1 RT-PCR
- 1.2.4.2.2 RT-LAMP assays
- 1.2.4.2.3 NGS techniques
- 1.2.4.2.4 Serum-based antigen/antibody-based detection techniques
- 1.2.4.3 Novel Point-of-Care approaches and their limitations
- 1.2.5 Late detection issues
- 1.2.6 Monitoring of severely affected COVID-19 patients
- 1.2.7 Other health aspects due to COVID-19 and related health management factors
- 1.2.7.1 Direct COVID-19 risk management
- 1.2.7.2 Medical and domestic waste management
- 1.2.7.3 Telehealth management
- 1.2.7.4 Wastewater management
- 1.2.7.5 Other health management factors
- 1.3 Conclusions
- References
- 2
- Virus-sampling technologies in different environments
- 2.1 Introduction
- 2.2 Methods of SARS-CoV-2 air sampling
- 2.2.1 Filtration
- 2.2.2 Impactor
- 2.2.3 Impinger
- 2.2.4 Cyclone
- 2.2.5 Electrostatic precipitator
- 2.2.6 MD-8 airscan
- 2.3 Literature review for SARS-CoV-2 sampling in air
- 2.4 Surface detection for SARS-CoV-2
- 2.4.1 Practical tips before sampling
- 2.4.2 Surface sampling area
- 2.4.3 Swab types.
- 2.5 Municipal wastewater for SARS-CoV-2 sampling
- 2.5.1 Sampling procedures for SARS-CoV-2 in municipal wastewater
- 2.6 SARS-CoV-2 in urine and stool
- 2.6.1 Sampling method for SARS-CoV-2 in urine and stool
- 2.7 SARS-CoV-2 sampling in food
- 2.8 SARS-CoV-2 detection techniques in air and surface samples
- 2.8.1 RT-PCR
- 2.8.2 Droplet digital PCR (ddPCR)
- 2.8.3 Sensor-based method
- 2.9 SARS-CoV-2 recognition in water
- 2.10 SARS-CoV-2 detection in solid wastes
- 2.11 Analysis techniques for SARS-CoV-2
- 2.12 Conclusion
- References
- 3
- Mechanism and transmission routes of COVID-19
- 3.1 Origin and transmission of Sars-CoV-2
- 3.2 Incidence and risk factors for COVID-19 severity
- 3.2.1 Hypertension
- 3.2.2 Diabetes
- 3.2.3 Cardiovascular disease
- 3.2.4 Chronic obstructive pulmonary disease
- 3.2.5 Renal diseases
- 3.2.6 Malignancy
- 3.2.7 Management of COVID-19 patients with comorbidities
- 3.3 SARS-CoV-2 transmission cycle
- 3.3.1 Airborne transmission
- 3.3.2 Fomite transmission
- 3.3.3 Other modes of transmission
- 3.4 Conclusion
- References
- II
- Remediation measures in waste and wastewater environments
- 4
- Presence, detection, and persistence of SARS-CoV-2 in wastewater and the sustainable remedial measures
- 4.1 Introduction
- 4.2 Occurrence, detection, and persistence of SARS-CoV-2 in wastewater, feces, slurry, or biosolids
- 4.2.1 Occurrence and detection of coronaviruses in wastewater
- 4.2.2 Methods for SARS-CoV-2 detection in wastewater
- 4.2.2.1 Virus detection in wastewater using RT-PCR/RT-qPCR
- 4.2.3 Persistence of coronaviruses in wastewater
- 4.2.3.1 Composition of wastewater
- 4.2.3.2 pH
- 4.2.3.3 Temperature
- 4.3 Removal of viruses from water and wastewater environment
- 4.4 Virus removal techniques from wastewater
- 4.4.1 Activated sludge treatment.
- 4.4.2 Membrane bioreactor
- 4.5 Mechanism of inactivation of coronaviruses in water environment using disinfectants
- 4.5.1 Chlorination pretreatment
- 4.5.2 Chlorine dioxide
- 4.5.3 Sodium hypochlorite
- 4.5.4 Ozone
- 4.5.5 Ultraviolet irradiation
- 4.6 Measures to ensure the protection of personnel and wastewater treatment workers from contacting COVID-19
- 4.6.1 Viral contamination risk assessment
- 4.6.2 Measures to protect wastewater treatment workers
- 4.7 Conclusion
- References
- 5
- A comprehensive study of COVID-19 in wastewater: occurrence, surveillance, and viewpoints on its remedy
- 5.1 Introduction
- 5.2 Wastewater: characterization and classification
- 5.2.1 Physical characterization of wastewater
- 5.2.2 Chemical characterization of wastewater
- 5.2.3 Biological characterization of wastewater
- 5.3 Study of municipal wastewater: characterization and classification
- 5.4 Study of health care wastewater: characterization and classification
- 5.4.1 Hazardous health care waste
- 5.4.2 Nonhazardous health care waste
- 5.5 Characteristics of coronavirus
- 5.6 Occurrence and persistence of COVID-19 in wastewater
- 5.7 Detection of coronavirus in wastewater
- 5.8 Inactivation mechanism of COVID-19 in wastewater
- 5.9 Remedial approach
- 5.10 Conclusion and future perspectives
- References
- Further reading
- 6
- Route of SARS-CoV-2 in sewerage and wastewater treatment plants: dilution, decay, removal, and environmental tr ...
- 6.1 Introduction
- 6.2 Dilution of SARS-CoV-2 from the feces to the sewerage
- 6.3 SARS-CoV-2 load of in raw wastewater
- 6.4 The approach for SARS-CoV-2 detection in sewerage is an open issue
- 6.5 Decay of SARS-CoV-2 in wastewater due to adverse environmental conditions
- 6.6 Reduction of SARS-CoV-2 in wastewater treatment plants.
- 6.7 Potential fecal-oral transmission associated with sewerage
- 6.7.1 Aerosolization of wastewater
- 6.7.2 Overflows in municipal combined sewer systems
- 6.7.3 Flooding events in urban areas
- 6.7.4 Discharge of untreated or treated wastewater into surface water bodies
- 6.8 Conclusions and future perspective
- References
- 7
- Impediments of coronavirus in healthcare wastewater treatment and ways to ameliorate them
- 7.1 Introduction
- 7.2 Municipal wastewater: Definition, classification, and characterization
- 7.2.1 Characterization of wastewater pertaining to epidemiological index
- 7.2.1.1 Suspended solids (SS)
- 7.2.1.2 Chemical oxygen demand (COD) and biological oxygen demand (BOD)
- 7.2.1.3 Total phosphorus (TP)
- 7.2.1.4 Total Nitrogen (TN)
- 7.2.1.5 Pathogens
- 7.2.2 Possible disinfection routes of MWW
- 7.2.2.1 UV irradiation
- 7.2.2.2 Electrochemical (EC) disinfection
- 7.2.2.3 Ozone disinfection
- 7.2.2.4 Peracetic acid
- 7.2.2.5 Ultrasonication
- 7.2.2.6 Chlorination
- 7.3 Healthcare wastewater (HWW)
- 7.3.1 HWW management
- 7.3.2 HWW collection methods
- 7.3.2.1 Central system
- 7.3.2.2 Decentralized system
- 7.3.3 Pretreatment of HWW
- 7.3.4 Medical wastewater treatment in COVID times
- 7.3.4.1 Wuhan: A case study
- 7.3.5 Mandatory treatment and disinfection plans
- 7.3.5.1 Disinfection procedure
- 7.4 Occurrence and survival of COVID-19 in wastewater, urine, and biosolids
- 7.4.1 The survival of SARS-CoV-2 in urine and the urogenital system
- 7.4.2 Human pathogens can be monitored in sewage
- 7.4.2.1 A paper-strip urine test kit was developed to detect COVID-19
- 7.4.3 Novel coronavirus infection and gastrointestinal tract
- 7.4.4 Wastewater-based epidemiology
- 7.4.5 Gastrointestinal tract may be another site of viral replication
- 7.4.6 Viruses and the culture methods.
- 7.4.7 Waterborne viral outbreaks related to virus
- 7.4.8 Transport of virus in the environment
- 7.4.9 Survival of virus in the environment
- 7.4.10 Microbial tracking tools (viruses)
- 7.5 Measures to the protection of personnel and wastewater treatment workers from contracting COVID-19
- 7.5.1 Safe management of fecal waste and wastewater
- 7.5.2 Personal Protection Equipment (PPE)
- 7.5.2.1 Level A protection
- 7.5.2.2 Level B protection
- 7.5.2.3 Level C protection
- 7.5.2.4 Level D protection
- 7.5.2.5 Goggles
- 7.5.3 Masks
- 7.5.3.1 Surgical masks
- 7.5.3.2 Respirators
- 7.5.3.3 Air-purifying respirators (APR)
- 7.5.3.4 Powered air-purifying respirators (PAPRs)
- 7.5.3.5 Supplied-air respirators (SAR)
- 7.5.4 Gloves
- 7.5.5 Face shields
- 7.5.6 Liquid-repellent coveralls, gowns, and aprons
- 7.6 Recycling of PPE
- 7.7 Training for workers
- 7.8 Vaccination recommendation for workers
- 7.9 Conclusion
- References
- 8
- Handling and treatment strategies of biomedical wastes and biosolids contaminated with SARS-CoV-2 in waste envi ...
- 8.1 Introduction
- 8.2 Solid wastes from health care units
- 8.2.1 Classification
- 8.2.1.1 Infectious waste15
- 8.2.1.2 Pathological wastes15
- 8.2.1.3 Sharps15
- 8.2.1.4 Pharmaceutical waste15
- 8.2.1.5 Chemical wastes15
- 8.2.1.6 Radioactive wastes15
- 8.2.2 Modes of transmission of SARS-CoV-2
- 8.3 Occurrence of virus in biomedical waste
- 8.4 A comparative study on viruses potentially similar to COVID-19
- 8.5 Survival of SARS-CoV-2 on different surfaces
- 8.6 Safe handling and management of health care waste generated through the care of COVID-19 patients
- 8.6.1 Preparing a waste management plan as part of COVID-19 patient care
- 8.7 Collection, transport, and storage of waste
- 8.7.1 Collection
- 8.7.2 Storage
- 8.8 Treatment and disposal
- 8.8.1 Treatment.